Toxicokinetic analysis of losartan during gestation and lactation in the rat

Teratology

Volumn 53, Issue 4, 1996, Pages 245-252

  Spence, S G ^a   Zacchei, A G ^a   Lee, L L ^a   Baldwin, C L ^a   Berna, R A ^a   Mattson, B A ^a   Eydelloth, R S ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 BUTYL 4 CHLORO 1 [[2' (1H TETRAZOL 5 YL) 4 BIPHENYLYL]METHYL] 5 IMIDAZOLECARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; LOSARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG MILK LEVEL; DRUG TISSUE LEVEL; FEMALE; FETUS; FETUS BLOOD; GESTATIONAL AGE; KIDNEY DISEASE; KIDNEY INJURY; LACTATION; NEWBORN; NEWBORN MORTALITY; NONHUMAN; ONTOGENY; ORAL DRUG ADMINISTRATION; PREGNANCY; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TERATOGENESIS; TERATOGENICITY; WEANING; WEIGHT REDUCTION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; AREA UNDER CURVE; BIPHENYL COMPOUNDS; FEMALE; IMIDAZOLES; LACTATION; LOSARTAN; MILK; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; TETRAZOLES;

EID: 0029757508     PISSN: 00403709     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9926(199604)53:4<245::AID-TERA7>3.0.CO;2-1     Document Type: Article

References (27)

1. Barr, M., and M.M. Cohen (1991) ACE inhibitor fetopathy and hypocalavaria: The kidney-skull connection. Teratology, 44:485-495.
2. Campbell, D.J., and J.F. Hadener (1986) Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat. J. Clin. Invest., 78:31-39.
3. Cozens, D.D., S.J. Barton, R. Clark, E.W. Hughes, J.M. Offer, and Y. Yamamoto (1987) Reproductive toxicity studies of rentiapril. Arzneim. Forsch. Drug Res., 37:164-169.
4. Datta, S., V.M. Hey, and B.J. Pluerry (1974) Effects of pregnancy and associated hormones in mouse intestine, in vivo and in vitro. Pflugers Arch. Eur. J. Physiol. 346:87-95.
5. Dostal, L.A., S.N. Kim, J.L. Schardein, and J.A. Anderson (1991) Fertility and perinatal/postnatal studies with the angiotensin-converting enzyme inhibitor, quinapril. Fund. Appl. Toxicol., 17:684-695.
6. Friberg, P., B. Sundelin, S.-O. Bohman, A. Bobik, H. Nilsson, A. Wickman, H. Gustafsson, J. Petersen, and M. Adams (1994) Renin-angiotensin system in neonatal rats: Induction of renal abnormalities in response to ACE inhibition or angiotensin II antagonism. Kidney Int., 45:485-492.
7. 1 receptor in the rat. Pediatr. Nephrol., 7:635-638.
8. 2 receptors in the developing rat fetus. J. Clin. Invest., 88:921-933.
9. Hanssens, M., M. Keirse, F. Vankelecom, and F. Van Assche (1991) Fetal and neonatal effects and treatment with angiotensin-converting enzyme inhibitors in pregnancy. Obstet. Gynecol., 78:128-135.
10. Kalinyak, J.E., and A.J. Perlman (1987) Tissue specific regulation of angiotensin mRNA accumulation by dexamethasone. J. Biol. Chem., 262:460-464.
11. Klein, K., W.J. Scott, K.E. Clark, and J.G. Wilson (1981) Indomethacin-placental transfer, cytotoxicity and teratology in the rat. Am. J. Obstet. Gynecol., 141:448-452.
12. Mendelsohn, F.A.O., G. Aquilera, J.M. Saavedra, R. Quirion, and K.F. Catt (1983) Characteristics and localization of angiotensin II receptors in pituitary, cirumventricular organs and kidney. Clin. Exp. Hypertens. Part A Theory Pract., A5:1081-1097.
13. Momma, K., and A. Takeo (1987) In vivo constriction of the ductus arteriosis by nonsteroidal anti-inflammatory drugs in near term fetal rat. Pediatr. Res., 22:567-572.
14. Olanoff, L.S., and J.M. Anderson (1980) Controlled release of tertacycline-III: A physiological pharmacokinetic model of the pregnant rat. J. Pharmacokinet. and Biopharmaceut., 8:599-620.
15. Pryde, P., A. Sedman, C. Nugent, and M. Barr (1993) Angiotensin-converting enzyme inhibitor fetopathy. J. Am. Soc. Nephrol., 3:1575-1582.
16. Robertson, R.T., D.A. Minsker, and D.L. Bokelman (1986) MK-421 (enalapril maleate): Fertility study in male and female rats. Jpn. J. Pharmacol. Toxicol., 14:25-41.
17. Schubiger, G., G. Flury, and J. Nussberger (1988) Enalapril for pregnancy-induced hypertension: Acute renal failure in a neonate. Ann. Intern. Med., 108:215-216.
18. Scott, L.D., R. Lester, D.H. Van Thiel, and A. Wald (1983) Pregnancy-related changes in small intestinal myoelectric activity in the rat. Gastroenterology, 84:301-305.
19. Siegl, P.K.S. (1993) Discovery of losartan, the first specific non-peptide angiotensin II receptor antagonist. J. Hypertens., 11(suppl 3): S19-S22.
20. Smith, R.D., C.S. Smith, A. Goldberg, and P.B.M.W.M. Timmermans (submitted) Losartan Potassium (COZAAR™). Drugs Today.
21. Sonawane, B.R., and S.J. Yafee (1986) Physiologic disposition of drugs in the fetus and newborn. In Drug and Chemical Action in Pregnancy. S. Fabro and A.R. Scialli, eds. Marcel Decker, Inc., New York, pp. 103-121.
22. 1-selective angiotensin II receptor antagonist Losartan in rats. Teratology, 51:367-382.
23. 1-selective angiotensin II receptor antagonist losartan in rats. Teratology, 51:383-397.
24. Stock, B., M. Dean and G. Levy (1980) Serum protein binding of drugs during and after pregnancy in rats. J. Pharmacol. Exp. Ther., 212: 264-268.
25. Tufro-McReddie, A., J.K. Harrison, A.D. Everett, and R.A. Gomez (1993) Ontogeny of type I angiotensin II receptor gene expression in the rat. J. Clin. Invest., 91:530-537.
26. Weber, M.A. (1992) Clinical experience with the angiotensin II receptor antagonist losartan. A preliminary report. Am. J. Hypertens. 5:247S-251S.
27. Wilkes, B.M., E. Krin, and P.F. Mento (1985) Evidence for a functional renin-angiotensin system in full-term fetoplacental unit. Am. J. Physiol., 249:E366-E373.